Call Options

14 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $75,820 - $123,386
-3,400 Reduced 10.37%
29,400 $674,000
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $249,085 - $493,520
15,500 Added 89.6%
32,800 $947,000
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $13,704 - $21,528
-800 Reduced 4.42%
17,300 $356,000
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $390,597 - $533,950
18,100 New
18,100 $489,000
Q1 2023

May 15, 2023

SELL
$22.92 - $33.76 $220,032 - $324,096
-9,600 Reduced 51.61%
9,000 $206,000
Q4 2022

Feb 14, 2023

SELL
$25.44 - $59.78 $590,208 - $1.39 Million
-23,200 Reduced 55.5%
18,600 $506,000
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $379,841 - $530,700
8,700 Added 26.28%
41,800 $2.25 Million
Q2 2022

Aug 15, 2022

BUY
$28.82 - $77.35 $636,922 - $1.71 Million
22,100 Added 200.91%
33,100 $1.39 Million
Q1 2022

May 16, 2022

SELL
$48.25 - $100.49 $743,050 - $1.55 Million
-15,400 Reduced 58.33%
11,000 $737,000
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $532,260 - $722,580
6,000 Added 29.41%
26,400 $2.65 Million
Q3 2021

Nov 12, 2021

SELL
$98.77 - $132.17 $671,636 - $898,755
-6,800 Reduced 25.0%
20,400 $2.47 Million
Q2 2021

Aug 06, 2021

BUY
$109.77 - $165.68 $1.38 Million - $2.09 Million
12,600 Added 86.3%
27,200 $3.48 Million
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $1.44 Million - $2.02 Million
11,300 Added 342.42%
14,600 $2.14 Million
Q4 2020

Feb 12, 2021

BUY
$99.96 - $135.93 $329,868 - $448,569
3,300 New
3,300 $416,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.59B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.